<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="medical and health care (CPAM) recommend using anti-SARS properties of" exact="lopinavir" post="and ritonavir capsule for older age COVID-19 patients with"/>
 <result pre="health care (CPAM) recommend using anti-SARS properties of lopinavir and" exact="ritonavir" post="capsule for older age COVID-19 patients with the underlying"/>
 <result pre="et al. (2020) reported that two important class of compounds," exact="theophylline" post="and pyrimidone drugs as possible inhibitors of RNA binding"/>
 <result pre="regions have an antiparallel Î²-sheet structure, third region has five" exact="alpha" post="helices arranged into a cluster. The third region is"/>
 <result pre="inhibitors, tipranavir, saquinavir, ritonavir, nelfinavir, lopinavir, indinavir, darunavir, atazanavir, and" exact="amprenavir" post="are widely reported to be able to deactivate Mpro"/>
 <result pre="production. In this respect, Wilson et al., showed that hexamethylene" exact="amiloride" post="inhibitor has shown to block the E-protein ion channel"/>
 <result pre="efforts to develop a novel therapy and treatment. For example," exact="Chloroquine" post="and Hydroxychloroquine, old drugs, have been used to treat"/>
 <result pre="sun allergies for more than sixty years. The activity of" exact="hydroxychloroquine" post="on viruses is probably same as that of chloroquine"/>
 <result pre="of hydroxychloroquine on viruses is probably same as that of" exact="chloroquine" post="since the mechanism of the action of these two"/>
 <result pre="mechanism of the action of these two molecules is identical." exact="Chloroquine" post="as an antimalarial and autoimmune disease drugs has shown"/>
 <result pre="cell culture has been prevented (Vincent et al., 2005). The" exact="hydroxychloroquine" post="has shown a potent efficacy in treating patients with"/>
 <result pre="COVID-19 pneumonia. More than hundred patients showed the superiority of" exact="chloroquine" post="compared with treatment of standard care in terms of"/>
 <result pre="n.d.; Gao et al., 2020). Colson group have suggested that" exact="chloroquine" post="and hydroxychloroquine as available weapons to fight COVID-19 (Colson"/>
 <result pre="et al., 2020). Colson group have suggested that chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19 (Colson et al.,"/>
 <result pre="weapons to fight COVID-19 (Colson et al., 2020). In 2014-2017," exact="ivermectin" post="antiviral drug used for phase 3 treatment of dengue"/>
 <result pre="M. Wang et al. (2020) study reported that remdesivir and" exact="chloroquine" post="are highly effective in the control of COVID-19 infection"/>
 <result pre="not to be effective for COVID-19 (Baden &amp;amp; Rubin, 2020)." exact="Azithromycin" post="has been displayed an antiviral property against Zika and"/>
 <result pre="Gautret group have treated successfully chronic disease patients with long-term" exact="hydroxychloroquine" post="medicines with 600â€‰mg per day for 12 to 18â€‰months."/>
 <result pre="and 16 control patients. Among hydroxychloroquine-treated patients, six patients received" exact="azithromycin" post="with 500â€‰mg on day 1 followed by 250â€‰mg per"/>
 <result pre="next four days. At day 6, 100% patients treated with" exact="hydroxychloroquine" post="and azithromycin combination have cured comparing with 57.1% in"/>
 <result pre="days. At day 6, 100% patients treated with hydroxychloroquine and" exact="azithromycin" post="combination have cured comparing with 57.1% in patients treated"/>
 <result pre="combination have cured comparing with 57.1% in patients treated with" exact="hydroxychloroquine" post="only, and 12.5% in the control group. Finally, they"/>
 <result pre="and 12.5% in the control group. Finally, they found that" exact="hydroxychloroquine" post="and azithromycin combination have cured the COVID-19 patients but"/>
 <result pre="in the control group. Finally, they found that hydroxychloroquine and" exact="azithromycin" post="combination have cured the COVID-19 patients but the drawback"/>
 <result pre="doses of the flu drug oseltamivir combined with HIV drugs" exact="lopinavir" post="and ritonavir could improve the conditions of several COVID-19"/>
 <result pre="the flu drug oseltamivir combined with HIV drugs lopinavir and" exact="ritonavir" post="could improve the conditions of several COVID-19 patients at"/>
 <result pre="promotive association for medical and health care) recommends to take" exact="lopinavir" post="400â€‰mg, ritonavir 100â€‰mg (two tablets by mouth twice in"/>
 <result pre="for medical and health care) recommends to take lopinavir 400â€‰mg," exact="ritonavir" post="100â€‰mg (two tablets by mouth twice in daily) or"/>
 <result pre="ritonavir 100â€‰mg (two tablets by mouth twice in daily) or" exact="chloroquine" post="(500â€‰mg tablet by mouth twice in daily) for older"/>
 <result pre="patients with under underlying conditions and serious symptoms. In case" exact="chloroquine" post="is unavailable, consider to use of hydroxychloroquine (400â€‰mg by"/>
 <result pre="symptoms. In case chloroquine is unavailable, consider to use of" exact="hydroxychloroquine" post="(400â€‰mg by mouth once daily). It cannot be recommended"/>
 <result pre="by mouth once daily). It cannot be recommended to take" exact="ribavirin" post="and interferon drug because of the high risk for"/>
 <result pre="these drugs may be considered if treatment with lopinavir, ritonavir," exact="chloroquine" post="or hydroxychloroquine are ineffective (Chu et al., 2004; Gao"/>
 <result pre="may be considered if treatment with lopinavir, ritonavir, chloroquine or" exact="hydroxychloroquine" post="are ineffective (Chu et al., 2004; Gao et al.,"/>
 <result pre="drugs have become promises, other are being ruled out including" exact="lopinavir" post="and ritonavir, mix of two drugs used to treat"/>
 <result pre="Mpro with each inhibitor of ritonavir, lopinavir, Azithromycin, hydroxychloroquine, N3," exact="ribavirin" post="and new inhibitors based on free energy calculations. 4."/>
 <result pre="Heart, Lung, and Blood Instituteâ€™s AsthmaNet (2015). Early Administration of" exact="azithromycin" post="and prevention of severe lower respiratory tract illnesses in"/>
 <result pre="NhanT., de PinaJ. J., RolainJ. M., RaoultD., &amp;amp; MussoD. (2018)." exact="Azithromycin" post="inhibits the replication of Zika virus. Journal of Antivirals"/>
 <result pre="59(3), 252â€&quot;256. 10.1136/thorax.2003.01265814985565 ColsonP., RolainJ.-M., LagierJ.-C., BrouquiP., &amp;amp; RaoultD. (2020)." exact="Chloroquine" post="and hydroxychloroquine as available weapons to fight COVID-19. International"/>
 <result pre="10.1136/thorax.2003.01265814985565 ColsonP., RolainJ.-M., LagierJ.-C., BrouquiP., &amp;amp; RaoultD. (2020). Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19. International Journal of"/>
 <result pre="https://pdbj.org/featured/covid-19. Retrieved from https://pdbj.org/featured/covid-19 GaoJ., TianZ., &amp;amp; YangX. (2020). Breakthrough:" exact="Chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="HonorÃ©S., ColsonP., ChabriÃ¨reE., La ScolaB., RolainJ.-M., BrouquiP., &amp;amp; RaoultD. (2020)." exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVID-19: Results of"/>
 <result pre="ChabriÃ¨reE., La ScolaB., RolainJ.-M., BrouquiP., &amp;amp; RaoultD. (2020). Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: Results of an open-label"/>
 <result pre="studies of drug repurposing and synergism of lopinavir, oseltamivir and" exact="ritonavir" post="binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular"/>
 <result pre="MaheswariU., ParthasarathyK., NgL., LiuD. X., &amp;amp; GongX. (2007). Conductance and" exact="amantadine" post="binding of a pore formed by a lysine-flanked transmembrane"/>
 <result pre="RollinP. E., KsiazekT. G., SeidahN. G., &amp;amp; NicholS. T. (2005)." exact="Chloroquine" post="is a potent inhibitor of SARS coronavirus infection and"/>
 <result pre="LiuJ., XuM., ShiZ., HuZ., ZhongW., &amp;amp; XiaoG. (2020). Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="(n.d). Retrieved from https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 WilsonL., GageP., &amp;amp; EwartG. (2006). Hexamethylene" exact="amiloride" post="blocks E protein ion channels and inhibits coronavirus replication."/>
 <result pre="SunY., LiX., XuK.-F., WeiY., JinN., &amp;amp; JiangC. (2013). Anti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza A H5N1"/>
</results>
